Why Teladoc Health Is Sinking Today
Teladoc Health (NYSE: TDOC), a coronavirus stock if ever there was one, was trading slightly down in mid-afternoon action. Curiously, this was despite a significant analyst recommendation upgrade and price target increase.
Analyst Ravi Misra shifted his recommendation on the stock to buy from the previous hold. In doing so, he increased his price target by what's probably some kind of record lately -- to $252 per share from $157.
Misra is basing his changes on the ever-snowballing migration to remote medical services and the recently announced acquisition of Livongo Health (NASDAQ: LVGO), another healthcare sector high flyer.
Source Fool.com
